The Business Times
SUBSCRIBERS

Surgical platform UltraGreen targets Asia for growth

Singapore is not being ruled out as a potential listing location as the company seeks to tap its largest market

Summarise
Benjamin Cher

Benjamin Cher

Published Wed, Aug 20, 2025 · 07:00 AM
    • “If the Asean market is where I’m going to see the largest growth, then I should be looking at potentially Asean as a place to be,” says UltraGreen co-CEO Ravinder Sajwan.
    • “If the Asean market is where I’m going to see the largest growth, then I should be looking at potentially Asean as a place to be,” says UltraGreen co-CEO Ravinder Sajwan. PHOTO: ULTRAGREEN

    [SINGAPORE] Medical procedures can be risky. One company is providing data that could help reduce complications from surgery.

    Now, with Singapore in the centre of its plans, UltraGreen is looking to tap the sizeable Asian market for growth.

    The company’s fluorescent dye and artificial intelligence (AI) platform gives surgeons an “inside look” into living tissue, by measuring and monitoring blood flow in the human tissue.

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    Medical devicesSGX

    Copyright SPH Media. All rights reserved.

    Reuse this contentFeedback
    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More